✦ LIBER ✦
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in Australia
✍ Scribed by Tilden, D.; Cottrell, S.; Tocchini, L.; Frenzel, C.; Bonney, M.A.
- Book ID
- 122282254
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 72 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.